Novo Integrated Sciences Balance Sheet Health
Financial Health criteria checks 2/6
Novo Integrated Sciences has a total shareholder equity of $9.7M and total debt of $2.6M, which brings its debt-to-equity ratio to 26.4%. Its total assets and total liabilities are $35.3M and $25.7M respectively.
Key information
26.4%
Debt to equity ratio
US$2.55m
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.54m |
| Equity | US$9.66m |
| Total liabilities | US$25.66m |
| Total assets | US$35.33m |
Recent financial health updates
Recent updates
Slammed 49% Novo Integrated Sciences, Inc. (NASDAQ:NVOS) Screens Well Here But There Might Be A Catch
Jul 11
Novo Integrated Sciences, Inc. (NASDAQ:NVOS) Looks Just Right With A 26% Price Jump
Apr 18Novo Integrated Sciences prices 4M unit public offering at $.50/unit
Oct 14Novo Integrated Sciences expects to report over fivefold increase in Q3 revenue
Jul 11Health Check: How Prudently Does Novo Integrated Sciences (NASDAQ:NVOS) Use Debt?
Nov 23Does Novo Integrated Sciences (NASDAQ:NVOS) Have A Healthy Balance Sheet?
Aug 07Does Novo Integrated Sciences (NASDAQ:NVOS) Have A Healthy Balance Sheet?
Mar 02Financial Position Analysis
Short Term Liabilities: NVOS's short term assets ($6.2M) do not cover its short term liabilities ($22.7M).
Long Term Liabilities: NVOS's short term assets ($6.2M) exceed its long term liabilities ($3.0M).
Debt to Equity History and Analysis
Debt Level: NVOS's net debt to equity ratio (10.5%) is considered satisfactory.
Reducing Debt: NVOS's debt to equity ratio has increased from 9.8% to 26.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NVOS has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NVOS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 31.7% each year